Butyrate stimulates hepatic gluconeogenesis in mouse primary hepatocytes

Ji,Xueying; Zhou,Feiye; Zhang,Yuqing; Deng,Ruyuan; Xu,Wan; Bai,Mengyao; Liu,Yun; Shao,Li; Wang,Xiao; Zhou,Libin

doi:10.3892/etm.2018.7136

Butyrate stimulates hepatic gluconeogenesis in mouse primary hepatocytes

Authors:
- Xueying Ji
- Feiye Zhou
- Yuqing Zhang
- Ruyuan Deng
- Wan Xu
- Mengyao Bai
- Yun Liu
- Li Shao
- Xiao Wang
- Libin Zhou
View Affiliations

Affiliations: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, P.R. China, The Very Important Person Department, East Hospital, Shanghai Tongji University School of Medicine, Shanghai 200120, P.R. China
Published online on: December 28, 2018 https://doi.org/10.3892/etm.2018.7136
Pages: 1677-1687
Copyright: © Ji et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Butyrate is a major short-chain fatty acid (SCFA) produced by microbial fermentation of dietary fiber in the gastrointestinal tract. Butyrate is also a well‑known broad‑spectrum histone deacetylase (HDAC) inhibitor. Butyrate has been reported to improve energy metabolism in rodents, which is associated with its beneficial effects on skeletal muscle, brown fat tissue and pancreatic β‑cells. The present study investigated the direct effect of butyrate on hepatic gluconeogenesis in mouse primary hepatocytes and the underlying mechanism. Isolated mouse primary hepatocytes were incubated with sodium butyrate, other HDAC inhibitors and other SCFAs. Hepatic glucose production was measured and gluconeogenic gene expression was detected by polymerase chain reaction analysis. The phosphorylation of cyclic adenosine monophosphate (cAMP) response element binding protein (CREB) was assessed by western blot analysis. The results revealed that sodium butyrate dose‑dependently increased hepatic glucose production and gluconeogenic gene expression in isolated mouse primary hepatocytes. Trichostatin A, a potent broad‑spectrum HDAC inhibitor, had the opposite effect. Similar to sodium butyrate, propionate, which is another SCFA, promoted hepatic glucose production and gluconeogenic gene expression in the presence or absence of gluconeogenic substrates, which were further enhanced by cAMP. Furthermore, sodium butyrate also increased the accumulation of intracellular ATP and induced the phosphorylation of CREB in mouse hepatocytes. In conclusion, the present study suggested that butyrate stimulates hepatic gluconeogenesis and induces gluconeogenic gene expression as a substrate and cAMP/CREB signaling activator.

View Figures

View References

1	Ning G: Decade in review-type 2 diabetes mellitus: At the centre of things. Nat Rev Endocrinol. 11:636–638. 2015. View Article : Google Scholar : PubMed/NCBI
2	Ley RE, Turnbaugh PJ, Klein S and Gordon JI: Microbial ecology: Human gut microbes associated with obesity. Nature. 444:1022–1023. 2006. View Article : Google Scholar : PubMed/NCBI
3	Papathanasopoulos A and Camilleri M: Dietary fiber supplements: Effects in obesity and metabolic syndrome and relationship to gastrointestinal functions. Gastroenterology. 138:65–72.e1-e2. 2010. View Article : Google Scholar : PubMed/NCBI
4	Robertson MD, Currie JM, Morgan LM, Jewell DP and Frayn KN: Prior short-term consumption of resistant starch enhances postprandial insulin sensitivity in healthy subjects. Diabetologia. 46:659–665. 2003. View Article : Google Scholar : PubMed/NCBI
5	Robertson MD, Bickerton AS, Dennis AL, Vidal H and Frayn KN: Insulin-sensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism. Am J Clin Nutr. 82:559–567. 2005. View Article : Google Scholar : PubMed/NCBI
6	De Vadder F, Kovatcheva-Datchary P, Goncalves D, Vinera J, Zitoun C, Duchampt A, Bäckhed F and Mithieux G: Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell. 156:84–96. 2014. View Article : Google Scholar : PubMed/NCBI
7	Robertson MD, Currie JM, Morgan LM, Jewell DP and Frayn KN: Prior short-term consumption of resistant starch enhances postprandial insulin sensitivity in healthy subjects. Diabetologia. 46:659–665. 2003. View Article : Google Scholar : PubMed/NCBI
8	Gao Z, Yin J, Zhang J, Ward RE, Martin RJ, Lefevre M, Cefalu WT and Ye J: Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes. 58:1509–1517. 2009. View Article : Google Scholar : PubMed/NCBI
9	Lin HV, Frassetto A, Kowalik EJ Jr, Nawrocki AR, Lu MM, Kosinski JR, Hubert JA, Szeto D, Yao X, Forrest G and Marsh DJ: Butyrate and propionate protectagainst diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLoS One. 7:e352402012. View Article : Google Scholar : PubMed/NCBI
10	Ellis L, Hammers H and Pili R: Targeting tumor angiogenesis with histone deacetylase inhibitors. Cancer Lett. 280:145–153. 2009. View Article : Google Scholar : PubMed/NCBI
11	Haumaitre C, Lenoir O and Scharfmann R: Histone deacetylase inhibitors modify pancreatic cell fate determination and amplify endocrine progenitors. Mol Cell Biol. 28:6373–6383. 2008. View Article : Google Scholar : PubMed/NCBI
12	Khan S and Jena GB: Protective role of sodium butyrate, a HDAC inhibitor on beta-cell proliferation, function and glucose homeostasis through modulation of p38/ERK MAPK and apoptotic pathways: Study in juvenile diabetic rat. Chem Biol Interact. 213:1–12. 2014. View Article : Google Scholar : PubMed/NCBI
13	Li H, Gao Z, Zhang J, Ye X, Xu A, Ye J and Jia W: Sodium butyrate stimulates expression of fibroblast growth factor 21 in liver by inhibition of histone deacetylase 3. Diabetes. 61:797–806. 2012. View Article : Google Scholar : PubMed/NCBI
14	Hundal RS, Krssak M, Dufour S, Laurent D, Lebon V, Chandramouli V, Inzucchi SE, Schumann WC, Petersen KF, Landau BR and Shulman GI: Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes. 49:2063–2069. 2000. View Article : Google Scholar : PubMed/NCBI
15	Mihaylova MM, Vasquez DS, Ravnskjaer K, Denechaud PD, Yu RT, Alvarez JG, Downes M, Evans RM, Montminy M and Shaw RJ: Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis. Cell. 145:607–621. 2011. View Article : Google Scholar : PubMed/NCBI
16	Ip W, Shao W, Chiang YT and Jin T: The Wnt signaling pathway effector TCF7L2 is upregulated by insulin and represses hepatic gluconeogenesis. Am J Physiol Endocrinol Metab. 303:E1166–E1176. 2012. View Article : Google Scholar : PubMed/NCBI
17	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
18	Taddei A, Roche D, Bickmore WA and Almouzni G: The effects of histone deacetylase inhibitors on heterochromatin: Implications for anticancer therapy? EMBO Rep. 6:520–524. 2005. View Article : Google Scholar : PubMed/NCBI
19	Perry RJ, Borders CB, Cline GW, Zhang XM, Alves TC, Petersen KF, Rothman DL, Kibbey RG and Shulman GI: Propionate increases hepatic pyruvate cycling, anaplerosis and alters mitochondrial metabolism. J Biol Chem. 291:12161–12170. 2016. View Article : Google Scholar : PubMed/NCBI
20	Altarejos JY and Montminy M: CREB and the CRTC co-activators: Sensors for hormonal and metabolic signals. Nat Rev Mol Cell Biol. 12:141–151. 2011. View Article : Google Scholar : PubMed/NCBI
21	Screaton RA, Conkright MD, Katoh Y, Best JL, Canettieri G, Jeffries S, Guzman E, Niessen S, Yates JR III, Takemori H, et al: The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector. Cell. 119:61–74. 2004. View Article : Google Scholar : PubMed/NCBI
22	Perriello G, Pampanelli S, Del Sindaco P, Lalli C, Ciofetta M, Volpi E, Santeusanio F, Brunetti P and Bolli GB: Evidence of increased systemic glucose production and gluconeogenesis in an early stage of NIDDM. Diabetes. 46:1010–1016. 1997. View Article : Google Scholar : PubMed/NCBI
23	Zhang W, Patil S, Chauhan B, Guo S, Powell DR, Le J, Klotsas A, Matika R, Xiao X, Franks R, et al: FoxO1 regulates multiple metabolic pathways in the liver: Effects on gluconeogenic, glycolytic, and lipogenic gene expression. J Biol Chem. 281:10105–10117. 2006. View Article : Google Scholar : PubMed/NCBI
24	Xiong H, Guo B, Gan Z, Song D, Lu Z, Yi H, Wu Y, Wang Y and Du H: Butyrate upregulates endogenous host defense peptides to enhance disease resistance in piglets via histone deacetylase inhibition. Sci Rep. 6:270702016. View Article : Google Scholar : PubMed/NCBI
25	Donohoe DR, Collins LB, Wali A, Bigler R, Sun W and Bultman SJ: The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. Mol Cell. 48:612–626. 2012. View Article : Google Scholar : PubMed/NCBI
26	Anderson JW and Bridges SR: Short-chain fatty acid fermentation products of plant fiber affect glucose metabolism of isolated rat hepatocytes. Proc Soc Exp Biol Med. 177:372–376. 1984. View Article : Google Scholar : PubMed/NCBI
27	Massillon D, Arinze IJ, Xu C and Bone F: Regulation of glucose-6-phosphatase gene expression in cultured hepatocytes and H4IIE cells by short-chain fatty acids: Role of hepatic nuclear factor-4alpha. J Biol Chem. 278:40694–40701. 2003. View Article : Google Scholar : PubMed/NCBI
28	Diakos C, Prieschl EE, Saemann M, Novotny V, Bohmig G, Csonga R, Baumruker T and Zlabinger GJ: Novel mode of interference with nuclear factor of activated T-cells regulation in T-cells by the bacterial metabolite n-butyrate. J Biol Chem. 277:24243–24251. 2002. View Article : Google Scholar : PubMed/NCBI
29	Weber TE and Kerr BJ: Butyrate differentially regulates cytokines and proliferation in porcine peripheral blood mononuclear cells. Vet Immunol Immunopathol. 113:139–147. 2006. View Article : Google Scholar : PubMed/NCBI